Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors its investigation on behalf of Fulgent Genetics Inc. (“Fulgent” or the “Company”) (NASDAQ:FLGT)...
-
NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds Paysafe Limited (“Paysafe” or the “Company”) (NYSE:PSFE) investors of the April 7, 2026 deadline to seek the role of lead...
-
CALGARY, Alberta, March 19, 2026 (GLOBE NEWSWIRE) -- Maxim Power Corp. ("MAXIM" or the "Corporation") (TSX: MXG) announced today the release of financial and operating results for the fourth quarter...
-
Investors who lost money in PYPL after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
-
SUNNYVALE, Calif., March 19, 2026 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary...
-
Investors who lost money in SLNO after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
-
CALGARY, Alberta, March 19, 2026 (GLOBE NEWSWIRE) -- Condor Energies Inc. (“Condor” or the “Company”) (TSX:CDR), a Canadian based, internationally focused energy transition company focused on...
-
Investors who lost money in TCOM after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
-
(Dollar amounts are in thousands, in Canadian currency unless otherwise specified) GUELPH, Ontario, March 19, 2026 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by...
-
Pivotal Phase 2 with lasme-cel in r/r B-ALL (BALLI-01 trial) ongoing Phase 1: 83% ORR at RP2D and 100% ORR in the target Phase 2 populationIn target Phase 2 population: 100% of patients became...